M4MM
Compass Pathways Schedules Webinar on Psilocybin Therapy Advances for Depression and PTSD
LONDON – Compass Pathways plans to hold a virtual webinar to outline its steps toward launching a psilocybin-based therapy for treatment-resistant depression (TRD) and to share details on upcoming trials for post-traumatic stress disorder (PTSD). ...
Alabama Tightens Hemp Laws, Moves Medical Cannabis Licenses Forward
MONTGOMERY – Alabama regulators ushered in 2026 with a crackdown on unregulated hemp products containing THC, while inching closer to launching a long-delayed medical Cannabis program that could serve thousands of patients by spring. The ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...
Pre-Rolls Claim Top Spot in Canadian Cannabis Sales, Signal Shift Across the US
LOS ANGELES – Pre-rolled Cannabis joints have quietly moved ahead of loose flower to become the leading product in Canada's $5.8 billion 2024 legal market, a milestone that underscores a broader turn toward convenience in ...
LinkedIn Research Study: People Don’t Trust What You Say — They Trust What Others Say About You
LOS ANGELES- According to LinkedIn’s 2025 B2B Marketing Benchmark, video is now the #1 driver of trust — outperforming every other content format for credibility and conversion. The study shows that brands using video and ...
What’s Changing Now for Cannabis Operators: Lessons from Anaheim’s IgniteIt 2025
LOS ANGELES- The cannabis industry has always been about resilience, reinvention, and relentless adaptation. At this year’s IgniteIt Market Spotlight: California (formerly the Benzinga Cannabis Conference) in Anaheim, that message was louder than ever. The ...
Ohio Cannabis Sales Exceed $1.2B Since Recreational Launch
COLUMBUS – State records show Ohio's Cannabis sector has recorded more than $1.2 billion in combined medical and adult-use sales since recreational dispensaries opened in August 2024, a mark that underscores consistent buyer turnout in ...
Compass Pathways Schedules Webinar on Psilocybin Therapy Advances for Depression and PTSD
LONDON – Compass Pathways plans to hold a virtual webinar to outline its steps toward launching a psilocybin-based therapy for treatment-resistant depression (TRD) and to share details on upcoming trials for post-traumatic stress disorder (PTSD). ...
Alabama Tightens Hemp Laws, Moves Medical Cannabis Licenses Forward
MONTGOMERY – Alabama regulators ushered in 2026 with a crackdown on unregulated hemp products containing THC, while inching closer to launching a long-delayed medical Cannabis program that could serve thousands of patients by spring. The ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...
Alberta Leads in Psychedelic-Assisted Therapy Coverage
NEW YORK- Alberta Blue Cross's recent endorsement of insurance coverage for Psychedelic-Assisted Therapy signifies a pioneering move in Canadian healthcare, positioning Alberta as the first province to officially support and regulate such treatments. This development ...
Georgia Implements New Age Restrictions and Regulations on Hemp-Derived Products
NEW YORK- In a recent legislative development, Georgia is poised to enforce a new law restricting the sale of hemp-derived cannabinoid products, including CBD and intoxicating substances like delta-8 THC and delta-9 THC, to individuals ...
Awakn Life Sciences Expands into U.S. with Oklahoma Licensing Agreement
LOS ANGELES- Awakn Life Sciences Corp., a biotechnology company specializing in the development of medication-assisted treatments for addiction, particularly focusing on Alcohol Use Disorder (AUD), announced a significant expansion of its operations into the United ...
Ontario Anticipates Record Cannabis Revenue
LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...
University of Calgary Studies Psychedelic Treatment for Alcohol Use Disorder
LOS ANGELES- The University of Calgary, through its Hotchkiss Brain Institute, has embarked on a study to examine the potential of psychedelics, specifically psilocybin, in treating Alcohol Use Disorder (AUD). With plans to recruit 128 ...
Delaware Expands Medical Cannabis Program Access
NEW YORK- Delaware lawmakers have passed a significant bill aimed at broadening access to the state's medical cannabis program. On Thursday, the Delaware Senate approved a proposal that grants healthcare providers the discretion to certify ...
Imperial Brands Acquires Stake in Auxly Cannabis Group
LOS ANGELES- Imperial Brands has effectively become the largest shareholder of Auxly Cannabis Group, acquiring a 19.8% stake after converting over 123.4 million Canadian dollars ($90.6 million) in total debt into shares. This move was ...
North Carolina Senate Approves Medical Cannabis Legalization Bill
LOS ANGELES- The North Carolina Senate gave final approval to a medical cannabis legalization bill this week, sending the proposal to the House for consideration. Notably, the proposal would not legalize adult-use cannabis even under ...
Maryland Awards Social Equity Cannabis Licenses
LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...
Florida Supreme Court to Decide Fate of Cannabis Legalization
LOS ANGELES- The Florida Supreme Court is set to make a pivotal decision regarding the appearance of an adult-use cannabis legalization amendment on the November ballot, according to ClickOrlando. This determination follows a challenge by ...
Organigram Announces Investment in Open Book Extracts
NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...
Algernon Pharmaceuticals Advances Research Program
LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...
Germany Ushers in a New Era with Adult-Use Cannabis Legalization
BERLIN- As the clock struck midnight in Germany, transitioning from March 31st to April 1st, the nation embraced a historic shift in its drug policy landscape. Germany’s new adult-use cannabis legalization law, known as the ...
Colombia’s Medical Cannabis Exports Surge to $10.8 Million Amid Regulatory Enhancements
BOGOTA- In a notable advancement for Colombia's burgeoning medical cannabis industry, exports have seen a significant rise, reaching $10.8 million in 2023, as reported by ProColombia, a key government agency dedicated to fostering nontraditional Colombian ...
Glass House Brands Report Revenue and Profits
LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...
